MOSCOW, February 13Modern genetic diagnostics helps to find optimal ways to treat malignant tumors that have their own “individual” genetic characteristics, said Maria Vorontsova, Deputy Dean of the Faculty of Fundamental Medicine of Lomonosov Moscow State University, leading researcher at the National Medical Research Center for Endocrinology of the Russian Ministry of Health, and member of the Presidium of the Russian Association for the Promotion of Science.
““We can say that oncology is an individual genetic disease,” Vorontsova noted, speaking on Tuesday at the session “Genetic and genomic technologies: new opportunities in diagnostics and personalization” of the II Forum of Future Technologies in Moscow.
According to her, in the same tumor there may be several progenitor cells of tumor cell colonies that have mutations acquired during the patient’s life.
“Cancer arises as a result of mutations, and that is why, if we are talking about the role of genetic technologies in terms of practical application for the diagnosis and treatment of cancer, then oncology is undoubtedly an example of the implementation of such technologies,” noted the head of the scientific department of tumor biology growth of the Petrov National Medical Research Center for Oncology of the Ministry of Health of the Russian Federation Evgeniy Imyanitov.
He gave examples of work using genetic techniques carried out in this center. In particular, Imyanitov told how it was possible to increase the effectiveness of treatment of metastatic ovarian cancer in women.
According to Vorontsova, this is an example of the most obvious benefit of genetic diagnosis in oncology.
““Without these tests, we seem to be wandering in the dark,” she explained.
And in this case, instead of “average” therapy, approaches are used that can effectively combat the disease, Vorontsova added.
< br />
Свежие комментарии